HRP20010767A2 - PROCESS FOR PREPARING [S-(R*, S*)]-<F128M>b<F255D>-[[[1-[1-OXO-3-(4-PIPERIDINYL)PROPYL]-3-PIPERIDINYL]CARBONYL]AMINO]-3-PYRIDINEPROPANOIC ACID AND DERIVATIVES - Google Patents

PROCESS FOR PREPARING [S-(R*, S*)]-<F128M>b<F255D>-[[[1-[1-OXO-3-(4-PIPERIDINYL)PROPYL]-3-PIPERIDINYL]CARBONYL]AMINO]-3-PYRIDINEPROPANOIC ACID AND DERIVATIVES Download PDF

Info

Publication number
HRP20010767A2
HRP20010767A2 HR20010767A HRP20010767A HRP20010767A2 HR P20010767 A2 HRP20010767 A2 HR P20010767A2 HR 20010767 A HR20010767 A HR 20010767A HR P20010767 A HRP20010767 A HR P20010767A HR P20010767 A2 HRP20010767 A2 HR P20010767A2
Authority
HR
Croatia
Prior art keywords
formula
compound
image
salt
lower alkyl
Prior art date
Application number
HR20010767A
Other languages
English (en)
Croatian (hr)
Inventor
Judith
Michael Justus
Cynthia
Armin Rossler
Fridtjof
Kirk
Frank
Christian Weh
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of HRP20010767A2 publication Critical patent/HRP20010767A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR20010767A 1999-03-22 2000-03-21 PROCESS FOR PREPARING [S-(R*, S*)]-<F128M>b<F255D>-[[[1-[1-OXO-3-(4-PIPERIDINYL)PROPYL]-3-PIPERIDINYL]CARBONYL]AMINO]-3-PYRIDINEPROPANOIC ACID AND DERIVATIVES HRP20010767A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12567199P 1999-03-22 1999-03-22
PCT/US2000/007462 WO2000056730A1 (en) 1999-03-22 2000-03-21 PROCESS FOR PREPARING [S-(R*,S*)] -β -[[[1-[1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES

Publications (1)

Publication Number Publication Date
HRP20010767A2 true HRP20010767A2 (en) 2002-12-31

Family

ID=22420863

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010767A HRP20010767A2 (en) 1999-03-22 2000-03-21 PROCESS FOR PREPARING [S-(R*, S*)]-<F128M>b<F255D>-[[[1-[1-OXO-3-(4-PIPERIDINYL)PROPYL]-3-PIPERIDINYL]CARBONYL]AMINO]-3-PYRIDINEPROPANOIC ACID AND DERIVATIVES

Country Status (22)

Country Link
US (2) US6515130B1 (cs)
EP (1) EP1165543B1 (cs)
JP (1) JP2002540108A (cs)
KR (1) KR20020019895A (cs)
CN (1) CN1351600A (cs)
AT (1) ATE242235T1 (cs)
AU (1) AU775413B2 (cs)
BR (1) BR0010652A (cs)
CA (1) CA2368024A1 (cs)
CZ (1) CZ20013431A3 (cs)
DE (1) DE60003169T2 (cs)
DK (1) DK1165543T3 (cs)
ES (1) ES2199805T3 (cs)
HK (1) HK1046272A1 (cs)
HR (1) HRP20010767A2 (cs)
HU (1) HUP0201262A3 (cs)
MX (1) MXPA01009615A (cs)
PT (1) PT1165543E (cs)
SK (1) SK13562001A3 (cs)
UA (1) UA67832C2 (cs)
WO (1) WO2000056730A1 (cs)
YU (1) YU74601A (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01009617A (es) 1999-03-22 2003-07-21 Johnson & Johnson Sisntesis de propanoatos de 3-amino-3-arilo.
EP1430057B1 (en) * 2001-09-21 2005-08-31 Sanofi-Aventis Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives
HRP20170464T1 (hr) 2011-08-17 2017-05-19 Piramal Imaging Sa Spojevi za vezanje na glikoprotein iib/iiia specifičan za trombocite i njihova upotreba u vizualiziranju ugrušaka
HK1212706A1 (zh) 2013-02-12 2016-06-17 拜耳医药股份公司 结合至血小板特异性糖蛋白iib/iiia的金属螯合化合物
PL2958894T3 (pl) 2013-02-20 2020-06-29 Reuter Chemische Apparatebau E.K. Sposób wytwarzania enancjomerycznie wzbogaconej 3-aminopiperydyny
US20160068486A1 (en) 2013-04-22 2016-03-10 Reuter Chemische Apparatebau Kg Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine
KR102548998B1 (ko) 2020-03-31 2023-06-29 재단법인 아산사회복지재단 혈전영상을 위한 방사성의약품 및 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58243B1 (en) 1983-12-07 1993-08-11 Lonza Ag A process for the preparation of optically-active 3-amino carboxylic acids
US5254573A (en) 1991-10-15 1993-10-19 Monsanto Company Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
ES2164109T3 (es) 1993-09-22 2002-02-16 Fujisawa Pharmaceutical Co Derivados de n-(3-piperidinilcarbonil)-beta-alanina como antagonistas de paf.
US5770575A (en) * 1994-03-16 1998-06-23 Ortho Pharmaceutical Corporation Nipecotic acid derivatives as antithrombotic compounds
CA2248809A1 (en) * 1996-03-13 1997-09-18 Fujisawa Pharmaceutical Co., Ltd. N-[(r)-1-{3-(4-piperidyl)propionyl}-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist
PT923555E (pt) 1996-05-01 2005-09-30 Ortho Mcneil Pharm Inc Derivados carboxamida de pirrolidina, piperidina e hexa-hidroazepina para o tratamento de disturbios tromboticos
ZA976138B (en) 1996-07-12 1998-07-10 Searle & Co Asymmetric synthesis of chiral beta-amino acids
US6066651A (en) * 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders

Also Published As

Publication number Publication date
MXPA01009615A (es) 2003-07-21
UA67832C2 (uk) 2004-07-15
HU0201262D0 (cs) 2002-05-29
EP1165543A1 (en) 2002-01-02
CN1351600A (zh) 2002-05-29
ES2199805T3 (es) 2004-03-01
CZ20013431A3 (cs) 2003-04-16
DE60003169T2 (de) 2005-10-27
DK1165543T3 (da) 2003-09-29
ATE242235T1 (de) 2003-06-15
HUP0201262A3 (en) 2003-12-29
US20020137937A1 (en) 2002-09-26
AU3766100A (en) 2000-10-09
HUP0201262A2 (en) 2002-08-28
BR0010652A (pt) 2002-07-16
CA2368024A1 (en) 2000-09-28
JP2002540108A (ja) 2002-11-26
DE60003169D1 (de) 2003-07-10
WO2000056730A1 (en) 2000-09-28
KR20020019895A (ko) 2002-03-13
SK13562001A3 (sk) 2002-08-06
HK1046272A1 (zh) 2003-01-03
AU775413B2 (en) 2004-07-29
YU74601A (sh) 2004-05-12
EP1165543B1 (en) 2003-06-04
PT1165543E (pt) 2003-10-31
US6515130B1 (en) 2003-02-04

Similar Documents

Publication Publication Date Title
TWI679204B (zh) 苯并惡唑并惡嗪酮類化合物的製備方法及其中間體和晶型
Chivikas et al. Phenacyl-directed alkylation of imidazoles: a new regiospecific synthesis of 3-substituted L-histidines
HRP20010767A2 (en) PROCESS FOR PREPARING [S-(R*, S*)]-&lt;F128M&gt;b&lt;F255D&gt;-[[[1-[1-OXO-3-(4-PIPERIDINYL)PROPYL]-3-PIPERIDINYL]CARBONYL]AMINO]-3-PYRIDINEPROPANOIC ACID AND DERIVATIVES
SK152799A3 (en) Method of manufacturing sertindole
JP4208463B2 (ja) キノロンカルボン酸誘導体の製造に関する中間体
CA2383753C (en) Process for production of naphthyridine-3-carboxylic acid derivatives
ME00437B (me) Novi proces za sintezu n-/(s)-1- karboksibutil/-(s)- alaninskog estra i primjena u sintezi perindoprila
JP2014240399A (ja) イソキノリン誘導体又はその塩の新規製造方法
SI9500140A (en) Novel n-sulfoxy anhydrides, process for the preparation thereof and its use for the preparation of bioactive substances having ace inhibitory action
AU2007203969A1 (en) Process and intermediate for preparation of donepezil
JP3489116B2 (ja) 新規合成中間体およびアミノピペラジン誘導体の製造法
CN119306698B (zh) 一种制备扎维吉泮中间体的新方法
EP1698611A1 (en) Process for producing phenylacetic acid derivative
HU195232B (en) Process for production of derivatives of pirrol-2-acetyl-amin-acid and medical preparatives containing them
SU1512484A3 (ru) Способ получени ариламидов аминокислот или пептидов или их солей
EP1634879A1 (en) Method of selectively introducing amino substituent
CA2511989A1 (en) Novel benzamide derivatives and process for producing the same
WO1991015477A1 (es) Procedimiento para la obtencion de derivados del acido 6-fluor-1,4-dihidro-4-oxo-7-piperacinil-3-quinolincarboxilico y derivados de acrilato utilizados en dicho procedimiento
WO2012085935A2 (en) Compounds as inhibitors of renin
JP2000212199A (ja) １―［（ｓ）―３―アセチルチオ―２―メチルプロパノイル］―ｌ―プロリル―ｌ―フェニルアラニンの製造法及びその中間体
MXPA99010191A (en) Method of manufacturing sertindole

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20060208

Year of fee payment: 7

OBST Application withdrawn